Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Extract:
Based on this comprehensive report published by Gravitas Market Insights, the Hydrogel-based Drug Delivery Systems market is said to witness a significant growth during the forecast years between 2021 and 2028. Hydrogels are three-dimensional polymeric networks capable of absorbing small to large pharmacological molecules (NSAIDs, proteins, peptides), and so are widely employed in drug delivery. Hydrogel is a promising drug delivery technology because of its biocompatibility and biodegradability, as well as its controlled release profile.
Report Scope in detail:
This latest report edition of Hydrogel-based Drug Delivery Systems market has been added to our huge database of detailed reports and this envisions to shape the future of all the related businesses. Our team of learned research analysts have studied in-depth and curated the report based on several aspects which include the overview of the market, driving forces, growth rate, market trends, market size, opportunities and challenges of the market; along with detailed competitive analysis on the regional as well as global level. The Hydrogel-based Drug Delivery Systems market research report renders a thorough analysis of the market on a global aspect and aims on several market segmentation. This report also provides deeper perception into the latest trends of the market and pinpoints crucial product developments of the industry. Furthermore, the report collects numerous factors that have accredited to the growth of the market in the recent years.
Market Dynamics:
• One of the primary factors likely to drive the market for hydrogel-based drug delivery systems in the next years is increased investment and funding by leading pharmaceutical companies in R&D operations in quest of novel drugs, delivery systems, and diagnostics.
• A pharmaceutical company's capacity to generate effective formulations determines its profitability.
• Because the pharmaceutical sector is highly fragmented and competitive, large expenditures in R&D are undertaken to stay competitive.
Hydrogel-based Drug Delivery Systems Market Segmentation:
By Polymer Origin
• Natural
• Synthetic
• Hybrid
By Delivery Route
• Subcutaneous
• Oral Cavity
• Ocular
• Other
Regional Coverage
• North America
o United States
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Russia
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o Korea
o Australia
o Southeast Asia
o Rest of Asia-Pacific
• South America
o Brazil
o Argentina
o Colombia
o Rest of South America
• Middle East & Africa
o GCC
o South Africa
o Rest of Middle East & Africa
Competitive Analysis:
Eminent market players have been outlined in order to extract improved insights into the worldwide businesses. Our research reports offer all-inclusive information on various top most manufacturers that are operational across global regions. We provide company profiles which include detailed overview of the company, business information, business performance, crucial strategies implemented through the years.
Few of the Key Players Covered in Our Report:
• GALDERMA
• Johnson & Johnson
• Blairex Laboratories, Inc.
• Bausch and Lomb
• Medtronic
• Ferring B.V.
• Ocular Therapeutix, Inc.
• Endo International plc
• Akorn, Incorporated
• Tolmar Pharmaceuticals, Inc.
Impact of COVID19:
The COVID19 pandemic crippled the global economy, it resulted in a worldwide lockdown and this has majorly impacted numerous industries. Our industry experts are working round-the-clock to identify, accumulate and in-time deliver market analysis due to the effect of unprecedented decisions in COVID-19 repercussions on many businesses. The full version of this report will comprise the overall impact of the pandemic, and predicted alteration on the future outlook of the industry, by taking into the account the economic, political, technological and social parameters.
Section 1: Executive Summary
1.1. Hydrogel-based Drug Delivery Systems Market Industry 360° outline, Year 2016 - 2028
1.2. Business Model Trends
1.3. Growth Trends
1.4. Polymer Origin/Delivery Route Trends
1.5. Regional Trends
Section 2: Market Dynamics - Hydrogel-based Drug Delivery Systems Market Industry Insights
2.1. Growth Drivers
2.2. Opportunities
2.3. Industry challenges
2.4. SWOT Analysis
2.5. Porter's Analysis
2.6. Worldwide Industry Landscape, Year 2016 - 2028
2.7. Industry Segmentation
2.8. Technology & Invention landscape
2.9. Regional Landscape
2.9.1. North America
2.9.2. Europe
2.9.3. Asia-Pacific
2.9.4. South America
2.9.5. Middle East & Africa
2.10. Competitive Environment
Section 3: Global Hydrogel-based Drug Delivery Systems Market, By Polymer Origin
3.1. Segmentation Analysis, By Polymer Origin, 2016-2028
3.2. Market Share Segmentation Analysis, By Polymer Origin, 2016-2028
3.3. Natural
3.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
3.4. Synthetic
3.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
3.5. Hybrid
3.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
Section 4: Global Hydrogel-based Drug Delivery Systems Market, By Delivery Route
4.1. Segmentation Analysis, By Delivery Route, 2016-2028
4.2. Market Share Segmentation Analysis, By Delivery Route, 2016-2028
4.3. Subcutaneous
4.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
4.4. Oral Cavity
4.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
4.5. Ocular
4.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
4.6. Other
4.6.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
Section 5: Global Hydrogel-based Drug Delivery Systems Market, Regional Analysis
5.1. Global Hydrogel-based Drug Delivery Systems Market, Regional Analysis
5.2. North America, Country level Analysis
5.2.1. North America Hydrogel-based Drug Delivery Systems Market estimates and forecast with Growth rate analysis, By Polymer Origin, 2016 - 2028
5.2.2. North America Hydrogel-based Drug Delivery Systems Market estimates and forecast with Growth rate analysis, By Delivery Route, 2016 - 2028
5.2.3. United States
5.2.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.2.4. Canada
5.2.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.2.5. Mexico
5.2.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.3. Europe Country level Analysis
5.3.1. Europe Hydrogel-based Drug Delivery Systems Market estimates and forecast with Growth rate analysis, By Polymer Origin, 2016 - 2028
5.3.2. Europe Hydrogel-based Drug Delivery Systems Market estimates and forecast with Growth rate analysis, By Delivery Route, 2016 - 2028
5.3.3. UK
5.3.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.3.4. Germany
5.3.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.3.5. France
5.3.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.3.6. Italy
5.3.6.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.3.7. Spain
5.3.7.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.3.8. Russia
5.3.8.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.3.9. Rest of Europe
5.3.9.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.4. Asia-Pacific Country level Analysis
5.4.1. Asia-Pacific Hydrogel-based Drug Delivery Systems Market estimates and forecast with Growth rate analysis, By Polymer Origin, 2016 - 2028
5.4.2. Asia-Pacific Hydrogel-based Drug Delivery Systems Market estimates and forecast with Growth rate analysis, By Delivery Route, 2016 - 2028
5.4.3. China
5.4.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.4.4. India
5.4.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.4.5. Japan
5.4.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.4.6. Korea
5.4.6.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.4.7. Australia
5.4.7.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.4.8. Southeast Asia
5.4.8.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.4.9. Rest of Asia-Pacific
5.4.9.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.5. South America Country level Analysis
5.5.1. South America Hydrogel-based Drug Delivery Systems Market estimates and forecast with Growth rate analysis, By Polymer Origin, 2016 - 2028
5.5.2. South America Hydrogel-based Drug Delivery Systems Market estimates and forecast with Growth rate analysis, By Delivery Route, 2016 - 2028
5.5.3. Brazil
5.5.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.5.4. Argentina
5.5.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.5.5. Colombia
5.5.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.5.6. Rest of South America
5.5.6.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.6. Middle East & Africa Country level Analysis
5.6.1. MEA Hydrogel-based Drug Delivery Systems Market estimates and forecast with Growth rate analysis, By Polymer Origin, 2016 - 2028
5.6.2. MEA Hydrogel-based Drug Delivery Systems Market estimates and forecast with Growth rate analysis, By Delivery Route, 2016 - 2028
5.6.3. GCC
5.6.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.6.4. South Africa
5.6.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.6.5. Rest of Middle East & Africa
5.6.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
Section 6: Company Profile - Hydrogel-based Drug Delivery Systems Market
6.1. GALDERMA
6.1.1. Business Overview
6.1.2. Delivery Route & Service Offering
6.1.3. Overall Revenue
6.1.4. Strategic Outlook
6.2. Johnson & Johnson
6.2.1. Business Overview
6.2.2. Delivery Route & Service Offering
6.2.3. Overall Revenue
6.2.4. Strategic Outlook
6.3. Blairex Laboratories, Inc.
6.3.1. Business Overview
6.3.2. Delivery Route & Service Offering
6.3.3. Overall Revenue
6.3.4. Strategic Outlook
6.4. Bausch and Lomb
6.4.1. Business Overview
6.4.2. Delivery Route & Service Offering
6.4.3. Overall Revenue
6.4.4. Strategic Outlook
6.5. Medtronic
6.5.1. Business Overview
6.5.2. Delivery Route & Service Offering
6.5.3. Overall Revenue
6.5.4. Strategic Outlook
6.6. Ferring B.V.
6.6.1. Business Overview
6.6.2. Delivery Route & Service Offering
6.6.3. Overall Revenue
6.6.4. Strategic Outlook
6.7. Ocular Therapeutix, Inc.
6.7.1. Business Overview
6.7.2. Delivery Route & Service Offering
6.7.3. Overall Revenue
6.7.4. Strategic Outlook
6.8. Endo International plc
6.8.1. Business Overview
6.8.2. Delivery Route & Service Offering
6.8.3. Overall Revenue
6.8.4. Strategic Outlook
6.9. Akorn, Incorporated
6.9.1. Business Overview
6.9.2. Delivery Route & Service Offering
6.9.3. Overall Revenue
6.9.4. Strategic Outlook
6.10. Tolmar Pharmaceuticals, Inc.
6.10.1. Business Overview
6.10.2. Delivery Route & Service Offering
6.10.3. Overall Revenue
6.10.4. Strategic Outlook
*Market size and forecast will be provided from 2016-2028, and forecast period would be 2021-2028
*Details on financial performance and strategic moves and developments may not be captured for unlisted companies
*List of companies profiled in this TOC is tentative and may change after detailed analysis
| Price : US$ 3,500 |
Date : Dec 2024 |
| Category : Services |
Pages : 167 |
Request Sample 
Request Discount 
Inquire Before Buy
